463 related articles for article (PubMed ID: 36006570)
1. Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition.
Sharma B; Satija G; Madan A; Garg M; Alam MM; Shaquiquzzaman M; Khanna S; Tiwari P; Parvez S; Iqubal A; Haque SE; Khan MA
Inflammation; 2023 Feb; 46(1):56-87. PubMed ID: 36006570
[TBL] [Abstract][Full Text] [Related]
2. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
[TBL] [Abstract][Full Text] [Related]
3. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
Zhang Y; Zhao Y; Zhang J; Yang G
Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.
Van Zeller M; Dias D; Sebastião AM; Valente CA
J Alzheimers Dis; 2021; 83(3):939-961. PubMed ID: 34366341
[TBL] [Abstract][Full Text] [Related]
6. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
[TBL] [Abstract][Full Text] [Related]
7. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
[TBL] [Abstract][Full Text] [Related]
8. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
[TBL] [Abstract][Full Text] [Related]
9. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment.
Barczuk J; Siwecka N; Lusa W; Rozpędek-Kamińska W; Kucharska E; Majsterek I
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012243
[TBL] [Abstract][Full Text] [Related]
10. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D
J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease.
Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM
Cells; 2021 Apr; 10(4):. PubMed ID: 33916001
[TBL] [Abstract][Full Text] [Related]
12. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
[TBL] [Abstract][Full Text] [Related]
13. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis.
de Dios C; Abadin X; Roca-Agujetas V; Jimenez-Martinez M; Morales A; Trullas R; Mari M; Colell A
Transl Neurodegener; 2023 Mar; 12(1):10. PubMed ID: 36895045
[TBL] [Abstract][Full Text] [Related]
15. Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia.
Liu Y; Dai Y; Li Q; Chen C; Chen H; Song Y; Hua F; Zhang Z
Neurosci Lett; 2020 Sep; 736():135279. PubMed ID: 32726591
[TBL] [Abstract][Full Text] [Related]
16. Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction.
Qiu WQ; Pan R; Tang Y; Zhou XG; Wu JM; Yu L; Law BY; Ai W; Yu CL; Qin DL; Wu AG
Biomed Pharmacother; 2020 Oct; 130():110575. PubMed ID: 32768883
[TBL] [Abstract][Full Text] [Related]
17. Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer's Disease Patients.
La Rosa F; Zoia CP; Bazzini C; Bolognini A; Saresella M; Conti E; Ferrarese C; Piancone F; Marventano I; Galimberti D; Fenoglio C; Scarpini E; Clerici M
Cells; 2022 Jul; 11(14):. PubMed ID: 35883623
[TBL] [Abstract][Full Text] [Related]
18. A
Merighi S; Nigro M; Travagli A; Pasquini S; Borea PA; Varani K; Vincenzi F; Gessi S
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563447
[TBL] [Abstract][Full Text] [Related]
19. The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease.
Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
Ageing Res Rev; 2020 Dec; 64():101192. PubMed ID: 33059089
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation in Alzheimer's Disease: Focus on NLRP1 and NLRP3 Inflammasomes.
de Brito Toscano EC; Rocha NP; Lopes BNA; Suemoto CK; Teixeira AL
Curr Protein Pept Sci; 2021; 22(8):584-598. PubMed ID: 34530705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]